Q THERAPEUTICS

• Reversing Paralysis: Stem cell therapy aims to repair spinal cords afflicted by rare disorder

       Oct 8, 2018, 8:00 AM EDT

​

• InVivo Therapeutics Announces Joint Research Collaboration with Q Therapeutics, Inc.

       Oct 2, 2018, 8:00 AM EDT

​

• Q Therapeutics Receives Orphan Drug Designation for Transverse Myelitis

       Sept 26, 2018, 6:00 AM EDT

​

• Q Therapeutics Announces Joint Venture with REPROCELL

       Apr 23, 2018, 5:00 AM EDT

​

• Q Therapeutics Announces Research Collaboration with REPROCELL

       Dec 13, 2017, 7:00 AM EDT

​

• Q Therapeutics Expands Board of Directors With Appointment of Dr. Tom Parks as Independent Member
  Aug 7, 2017, 8:00 AM EDT

​

• FDA Allows Q-Cells® for First-In-Human Transverse Myelitis Trial
  Jul 25, 2017, 8:00 AM EDT

​

• Novel cellular therapeutic approach for ALS gets FDA clearance for first-in-human trials
  Jun 4, 2015, 8:00 AM EDT

​

• Q Therapeutics Expands Board of Directors With Appointment of Dr. Hunter Jackson as Independent Member
  Sep 23, 2014, 4:21 PM EDT

​

• Q Therapeutics Invited to Present at the Swedish-American Life Science Summit 2014
  Aug 21, 2014, 8:30 AM EDT

​

• Q Therapeutics Announces First U.S. Patent Relating to Fifth Patent Family on Neural Cells
  Jul 7, 2014, 8:30 AM EDT

​

• Q Therapeutics to Present at the National Investment Banking Association's 131st Investment Conference
  Jun 9, 2014, 8:30 AM EDT

​

• Q Therapeutics Issues Formal Corporate Update
  Apr 21, 2014, 8:30 AM EDT

​

• Mahendra Rao, MD, PhD Joins Q Therapeutics as Chief Strategy Officer
  Apr 1, 2014, 8:30 AM EDT

​

• Q Therapeutics to Present at Biotech Showcase™ 2014 to Be Held During JP Morgan Healthcare Conference in San Francisco
  Jan 8, 2014, 8:30 AM EST

​

• Q Therapeutics Receives Orphan Drug Designation From U.S. Food & Drug Administration for Q-Cells® for Treatment of ALS
  Nov 19, 2013, 8:30 AM EST

​

• Q Therapeutics CEO to Present at Third Annual Regen Med Partnering Forum at the 2013 Stem Cell Meeting on the Mesa
  Oct 8, 2013, 8:30 AM EDT

​

• Q Therapeutics Appoints Diane Jorkasky, MD, to Board of Directors
  Mar 14, 2013, 8:30 AM EDT

​

• Q Therapeutics to Present at the 15th Annual BIO CEO & Investor Conference
  Jan 31, 2013, 8:30 AM EST

​

• Q Therapeutics to Present at Biotech Showcase™ 2013 to Be Held During JP Morgan Healthcare Conference in San Francisco
  Jan 3, 2013, 8:30 AM EST

​

• Q Therapeutics' CFO and Vice President of Corporate Development, Steve Borst, Featured on theStockRadio.com
  Jan 2, 2013, 11:20 AM EST

​

• Q Therapeutics' Collaborators at Johns Hopkins Are Awarded Funding From National Institutes of Health
  Dec 27, 2012, 8:30 AM EST

​

• Q Therapeutics Issues Formal Update on Key Corporate and Operational Developments
  Dec 20, 2012, 8:30 AM EST

​

• Q Therapeutics Announces U.S. and Canadian Patent Awards
  Nov 28, 2012, 8:30 AM EST

​

• Q Therapeutics CEO to Present at 2012 Stem Cell Meeting on the Mesa
  Oct 25, 2012, 10:10 AM EDT

​

• Q Therapeutics, Inc. Selects Hanover|Elite as New Investor and Public Relations Counsel of Record
  Oct 24, 2012, 4:21 PM EDT

​

• U of U Cell Therapy Lab Collaborates with Q Therapeutics On Stem Cell Therapy to Fight Lou Gehrig’s Disease
  Apr 17, 2009, 12:00 AM EDT

​

• Q Therapeutics, Inc. Adds New Patent to its Portfolio
  Apr 14, 2009, 12:00 AM EDT

​

• Q Therapeutics and Johns Hopkins Researchers Collaborate on Study of Human Neural Glial Cells in Treatment of ALS
  Oct 21, 2008, 12:00 AM EDT

​

• Q Therapeutics Collaborates with Johns Hopkins to Study Use of Neural Cells in Treatment of ALS
  Jun 12, 2008, 12:00 AM EDT

​

• Buck Institute and Q Therapeutics Form Stem Cell Collaboration to Combat Parkinson's Disease
  Apr 14, 2008, 12:00 AM EDT

​

• Q Therapeutics Announces Series B Investment
  Feb 15, 2008, 12:00 AM EST

​

• Q Therapeutics Wins Biotechnology Innovation Award for 2007
  May 21, 2007, 12:00 AM EDT

​

• Q Therapeutics Announces New Stem Cell Patent
  May 8, 2007, 12:00 AM EDT

• InVivo Therapeutics Announces Joint Research Collaboration with Q Therapeutics, Inc.

       Oct 2, 2018, 8:00 AM EDT

​

• Q Therapeutics Receives Orphan Drug Designation for Transverse Myelitis

       Sept 26, 2018, 6:00 AM EDT

​

• Q Therapeutics Announces Joint Venture with REPROCELL

       Apr 23, 2018, 5:00 AM EDT

​

• Q Therapeutics Announces Research Collaboration with REPROCELL

       Dec 13, 2017, 7:00 AM EDT

​

• Q Therapeutics Expands Board of Directors With Appointment of Dr. Tom Parks as Independent Member
  Aug 7, 2017, 8:00 AM EDT

​

• FDA Allows Q-Cells® for First-In-Human Transverse Myelitis Trial
  Jul 25, 2017, 8:00 AM EDT

​

• Novel cellular therapeutic approach for ALS gets FDA clearance for first-in-human trials
  Jun 4, 2015, 8:00 AM EDT

​

• Q Therapeutics Expands Board of Directors With Appointment of Dr. Hunter Jackson as Independent Member
  Sep 23, 2014, 4:21 PM EDT

​

• Q Therapeutics Invited to Present at the Swedish-American Life Science Summit 2014
  Aug 21, 2014, 8:30 AM EDT

​

• Q Therapeutics Announces First U.S. Patent Relating to Fifth Patent Family on Neural Cells
  Jul 7, 2014, 8:30 AM EDT

​

• Q Therapeutics to Present at the National Investment Banking Association's 131st Investment Conference
  Jun 9, 2014, 8:30 AM EDT

​

• Q Therapeutics Issues Formal Corporate Update
  Apr 21, 2014, 8:30 AM EDT

​

• Mahendra Rao, MD, PhD Joins Q Therapeutics as Chief Strategy Officer
  Apr 1, 2014, 8:30 AM EDT

​

• Q Therapeutics to Present at Biotech Showcase™ 2014 to Be Held During JP Morgan Healthcare Conference in San Francisco
  Jan 8, 2014, 8:30 AM EST

​

• Q Therapeutics Receives Orphan Drug Designation From U.S. Food & Drug Administration for Q-Cells® for Treatment of ALS
  Nov 19, 2013, 8:30 AM EST

​

• Q Therapeutics CEO to Present at Third Annual Regen Med Partnering Forum at the 2013 Stem Cell Meeting on the Mesa
  Oct 8, 2013, 8:30 AM EDT

​

• Q Therapeutics Appoints Diane Jorkasky, MD, to Board of Directors
  Mar 14, 2013, 8:30 AM EDT

​

• Q Therapeutics to Present at the 15th Annual BIO CEO & Investor Conference
  Jan 31, 2013, 8:30 AM EST

​

• Q Therapeutics to Present at Biotech Showcase™ 2013 to Be Held During JP Morgan Healthcare Conference in San Francisco
  Jan 3, 2013, 8:30 AM EST

​

• Q Therapeutics' CFO and Vice President of Corporate Development, Steve Borst, Featured on theStockRadio.com
  Jan 2, 2013, 11:20 AM EST

​

• Q Therapeutics' Collaborators at Johns Hopkins Are Awarded Funding From National Institutes of Health
  Dec 27, 2012, 8:30 AM EST

​

• Q Therapeutics Issues Formal Update on Key Corporate and Operational Developments
  Dec 20, 2012, 8:30 AM EST

​

• Q Therapeutics Announces U.S. and Canadian Patent Awards
  Nov 28, 2012, 8:30 AM EST

​

• Q Therapeutics CEO to Present at 2012 Stem Cell Meeting on the Mesa
  Oct 25, 2012, 10:10 AM EDT

​

• Q Therapeutics, Inc. Selects Hanover|Elite as New Investor and Public Relations Counsel of Record
  Oct 24, 2012, 4:21 PM EDT

​

• U of U Cell Therapy Lab Collaborates with Q Therapeutics On Stem Cell Therapy to Fight Lou Gehrig’s Disease
  Apr 17, 2009, 12:00 AM EDT

​

• Q Therapeutics, Inc. Adds New Patent to its Portfolio
  Apr 14, 2009, 12:00 AM EDT

​

• Q Therapeutics and Johns Hopkins Researchers Collaborate on Study of Human Neural Glial Cells in Treatment of ALS
  Oct 21, 2008, 12:00 AM EDT

​

• Q Therapeutics Collaborates with Johns Hopkins to Study Use of Neural Cells in Treatment of ALS
  Jun 12, 2008, 12:00 AM EDT

​

• Buck Institute and Q Therapeutics Form Stem Cell Collaboration to Combat Parkinson's Disease
  Apr 14, 2008, 12:00 AM EDT

​

• Q Therapeutics Announces Series B Investment
  Feb 15, 2008, 12:00 AM EST

​

• Q Therapeutics Wins Biotechnology Innovation Award for 2007
  May 21, 2007, 12:00 AM EDT

​

• Q Therapeutics Announces New Stem Cell Patent
  May 8, 2007, 12:00 AM EDT

​

​

• InVivo Therapeutics Announces Joint Research Collaboration with Q Therapeutics, Inc.

       Oct 2, 2018, 8:00 AM EDT

​

• Q Therapeutics Receives Orphan Drug Designation for Transverse Myelitis

       Sept 26, 2018, 6:00 AM EDT

​

• Q Therapeutics Announces Joint Venture with REPROCELL

       Apr 23, 2018, 5:00 AM EDT

​

• Q Therapeutics Announces Research Collaboration with REPROCELL

       Dec 13, 2017, 7:00 AM EDT

​

• Q Therapeutics Expands Board of Directors With Appointment of Dr. Tom Parks as Independent Member
  Aug 7, 2017, 8:00 AM EDT

​

• FDA Allows Q-Cells® for First-In-Human Transverse Myelitis Trial
  Jul 25, 2017, 8:00 AM EDT

​

• Novel cellular therapeutic approach for ALS gets FDA clearance for first-in-human trials
  Jun 4, 2015, 8:00 AM EDT

​

• Q Therapeutics Expands Board of Directors With Appointment of Dr. Hunter Jackson as Independent Member
  Sep 23, 2014, 4:21 PM EDT

​

• Q Therapeutics Invited to Present at the Swedish-American Life Science Summit 2014
  Aug 21, 2014, 8:30 AM EDT

​

• Q Therapeutics Announces First U.S. Patent Relating to Fifth Patent Family on Neural Cells
  Jul 7, 2014, 8:30 AM EDT

​

• Q Therapeutics to Present at the National Investment Banking Association's 131st Investment Conference
  Jun 9, 2014, 8:30 AM EDT

​

• Q Therapeutics Issues Formal Corporate Update
  Apr 21, 2014, 8:30 AM EDT

​

• Mahendra Rao, MD, PhD Joins Q Therapeutics as Chief Strategy Officer
  Apr 1, 2014, 8:30 AM EDT

​

• Q Therapeutics to Present at Biotech Showcase™ 2014 to Be Held During JP Morgan Healthcare Conference in San Francisco
  Jan 8, 2014, 8:30 AM EST

​

• Q Therapeutics Receives Orphan Drug Designation From U.S. Food & Drug Administration for Q-Cells® for Treatment of ALS
  Nov 19, 2013, 8:30 AM EST

​

• Q Therapeutics CEO to Present at Third Annual Regen Med Partnering Forum at the 2013 Stem Cell Meeting on the Mesa
  Oct 8, 2013, 8:30 AM EDT

​

• Q Therapeutics Appoints Diane Jorkasky, MD, to Board of Directors
  Mar 14, 2013, 8:30 AM EDT

​

• Q Therapeutics to Present at the 15th Annual BIO CEO & Investor Conference
  Jan 31, 2013, 8:30 AM EST

​

• Q Therapeutics to Present at Biotech Showcase™ 2013 to Be Held During JP Morgan Healthcare Conference in San Francisco
  Jan 3, 2013, 8:30 AM EST

​

• Q Therapeutics' CFO and Vice President of Corporate Development, Steve Borst, Featured on theStockRadio.com
  Jan 2, 2013, 11:20 AM EST

​

• Q Therapeutics' Collaborators at Johns Hopkins Are Awarded Funding From National Institutes of Health
  Dec 27, 2012, 8:30 AM EST

​

• Q Therapeutics Issues Formal Update on Key Corporate and Operational Developments
  Dec 20, 2012, 8:30 AM EST

​

• Q Therapeutics Announces U.S. and Canadian Patent Awards
  Nov 28, 2012, 8:30 AM EST

​

• Q Therapeutics CEO to Present at 2012 Stem Cell Meeting on the Mesa
  Oct 25, 2012, 10:10 AM EDT

​

• Q Therapeutics, Inc. Selects Hanover|Elite as New Investor and Public Relations Counsel of Record
  Oct 24, 2012, 4:21 PM EDT

​

• U of U Cell Therapy Lab Collaborates with Q Therapeutics On Stem Cell Therapy to Fight Lou Gehrig’s Disease
  Apr 17, 2009, 12:00 AM EDT

​

• Q Therapeutics, Inc. Adds New Patent to its Portfolio
  Apr 14, 2009, 12:00 AM EDT

​

• Q Therapeutics and Johns Hopkins Researchers Collaborate on Study of Human Neural Glial Cells in Treatment of ALS
  Oct 21, 2008, 12:00 AM EDT

​

• Q Therapeutics Collaborates with Johns Hopkins to Study Use of Neural Cells in Treatment of ALS
  Jun 12, 2008, 12:00 AM EDT

​

• Buck Institute and Q Therapeutics Form Stem Cell Collaboration to Combat Parkinson's Disease
  Apr 14, 2008, 12:00 AM EDT

​

• Q Therapeutics Announces Series B Investment
  Feb 15, 2008, 12:00 AM EST

​

• Q Therapeutics Wins Biotechnology Innovation Award for 2007
  May 21, 2007, 12:00 AM EDT

​

• Q Therapeutics Announces New Stem Cell Patent
  May 8, 2007, 12:00 AM EDT